2021
Tvardi Therapeutics Raises $74 Million in Series B Financing to Advance Clinical Programs
June 23, 2021
Francis Medical Announces Positive Data from VAPOR 1 IDE Study for Water Vapor Ablation of Prostate Cancer
June 8, 2021
Baebies Announces FDA Acknowledgement of Emergency Use Notification for FINDER 1.5 Instrument and FINDER SARS-CoV-2 Test – RT-PCR within 17 Minutes
April 5, 2021
NX Prenatal Announces Initiation of a Clinical Study for the Detection of Placenta Accreta
April 1, 2021
Stimdia Medical Receives FDA Breakthrough Device Designation for the pdSTIM™ System Designed to Facilitate Weaning Patients from Mechanical Ventilation
March 18, 2021
Tvardi Therapeutics Appoints Michael Wyzga, Former CFO of Genzyme, to Board of Directors
March 11, 2021
NX Prenatal Expands Leading Patent Position in Exosome-Based Liquid Biopsy Tests in Maternal- Fetal Medicine
January 27, 2021
Renovia names new president and CEO; Completes enrollment for randomized controlled trial.
January 19, 2021
Knopp Biosciences Announces Positive Top-Line Results from the Phase 2 EXHALE Trial of Oral Dexpramipexole in Moderate-to-Severe Eosinophilic Asthma
January 14, 2021
InterShunt Announces Equity Financing Led by Solas BioVentures with participation from Arsenal Capital Management and a select group of industry executives.
January 11, 2021